Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastoma
The results suggest that PRGs may serve as a novel prognostic marker for NB patients to provide new immunotherapeutic targets for the clinical treatment of NB patients.
Authors
- Hanjun Yin
- Zhongya Xu
- Kai Zhou (ORCID: https://orcid.org/0000-0002-7320-291X)
- Qiyang Shen (ORCID: https://orcid.org/0000-0001-8963-1244)
- Xingyu Liu (ORCID: https://orcid.org/0000-0002-0352-7436)
- Xu Zhao (ORCID: https://orcid.org/0000-0002-2477-8023)
- Jinjiang Duan
Institutions
- Nanjing Children's Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1007/s12672-024-01518-8
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00